Your browser doesn't support javascript.
loading
A new oncolytic Vacciniavirus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery.
Ahmed, Jahangir; Chard, Louisa S; Yuan, Ming; Wang, Jiwei; Howells, Anwen; Li, Yuenan; Li, Haoze; Zhang, Zhongxian; Lu, Shuangshuang; Gao, Dongling; Wang, Pengju; Chu, Yongchao; Al Yaghchi, Chadwan; Schwartz, Joel; Alusi, Ghassan; Lemoine, Nicholas; Wang, Yaohe.
Afiliação
  • Ahmed J; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Chard LS; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Yuan M; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Wang J; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Howells A; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Li Y; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Li H; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Zhang Z; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Lu S; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Gao D; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Wang P; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Chu Y; National Centre for International Research in Cell and Gene Therapy, Zhengzhou University, Zhengzhou, Henan, China.
  • Al Yaghchi C; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Schwartz J; University of Illinois at Chicago, Chicago, Illinois, USA.
  • Alusi G; University of Illinois at Chicago, Chicago, Illinois, USA.
  • Lemoine N; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Wang Y; Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
J Immunother Cancer ; 8(1)2020 03.
Article em En | MEDLINE | ID: mdl-32217766
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Vaccinia virus / Vírus Oncolíticos / Terapia Viral Oncolítica / Imunidade / Neoplasias Pulmonares / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Vaccinia virus / Vírus Oncolíticos / Terapia Viral Oncolítica / Imunidade / Neoplasias Pulmonares / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2020 Tipo de documento: Article